My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Recombinant tissue plasminogen activator following paediatric cataract surgery.

    Mehta JS, Adams GG.

    Br J Ophthalmol. 2000 Sep;84(9):983-6.PMID: 10966949 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.

    Klais CM, Hattenbach LO, Steinkamp GW, Zubcov AA, Kohnen T.

    J Cataract Refract Surg. 1999 Mar;25(3):357-62.PMID: 10079440 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.

    Siatiri H, Beheshtnezhad AH, Asghari H, Siatiri N, Moghimi S, Piri N.

    Br J Ophthalmol. 2005 Nov;89(11):1458-61.PMID: 16234453 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment of intracameral fibrinous membranes with tissue plasminogen activator.

    Erol N, Ozer A, Topbas S, Yildirim N, Yurdakul S.

    Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):451-6.PMID: 14620747 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.

    Schmitz K, Greite JH, Bartenschlager EM.

    Ger J Ophthalmol. 1995 Mar;4(2):75-9.PMID: 7795512 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery]

    Oficjalska-Młyńczak J, Marek J, Zajac-Pytrus H, Nizankowska MH, Koziorowska M.

    Klin Oczna. 1996;98(6):423-5. Polish. PMID: 9340414 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.

    Wedrich A, Menapace R, Ries E, Polzer I.

    J Cataract Refract Surg. 1997 Jul-Aug;23(6):873-7.PMID: 9292671 [PubMed - indexed for MEDLINE]Related articles

    8.

    Treatment of total hyphema with relatively low-dose tissue plasminogen activator.

    Kim MH, Koo TH, Sah WJ, Chung SM.

    Ophthalmic Surg Lasers. 1998 Sep;29(9):762-6.PMID: 9760614 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.

    Georgiadis N, Boboridis K, Halvatzis N, Ziakas N, Moschou V.

    J Cataract Refract Surg. 2003 Apr;29(4):729-32.PMID: 12686240 [PubMed - indexed for MEDLINE]Related articles

    10.

    The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.

    Wedrich A, Menapace R, Mühlbauer-Ries E.

    Int Ophthalmol. 1994-1995;18(5):277-80.PMID: 7607808 [PubMed - indexed for MEDLINE]Related articles

    11.

    [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis]

    Chiseliţă D, Antohi I, Cionca D, Medvichi R, Cimpoeşu D.

    Oftalmologia. 2006;50(2):68-72. Romanian. PMID: 16927762 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.

    Heiligenhaus A, Steinmetz B, Lapuente R, Krallmann P, Althaus C, Steinkamp WK, Dick B.

    Br J Ophthalmol. 1998 Jul;82(7):810-5.PMID: 9924378 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations]

    Heiligenhaus A, Schilling H, Schilling M, Mellin KB.

    Ophthalmologe. 1996 Feb;93(1):49-53. German. PMID: 8867161 [PubMed - indexed for MEDLINE]Related articles

    14.

    Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.

    Lesser GR, Osher RH, Whipple D, Abrams GW, Cionni RJ.

    J Cataract Refract Surg. 1993 Mar;19(2):301-5.PMID: 8487179 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis.

    Riaz Y, Mehta JS, Fernando A, Ferguson V.

    Ann Acad Med Singapore. 2006 Oct;35(10):723-5.PMID: 17102897 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation]

    Xie L, Li S, Dong X, Cao J, Shi W, Guo P.

    Zhonghua Yan Ke Za Zhi. 1998 Jul;34(4):291-3. Chinese. PMID: 11877211 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye]

    Rehfeldt K, Höh H.

    Ophthalmologe. 1999 Sep;96(9):587-93. German. PMID: 10501987 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.

    Wu TT, Wang HH.

    Eye (Lond). 2009 Jan;23(1):101-7. Epub 2007 Sep 28.PMID: 17901882 [PubMed - indexed for MEDLINE]Related articles

    19.

    Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.

    Ozveren F, Eltutar K.

    J Cataract Refract Surg. 2004 Aug;30(8):1727-31.PMID: 15313298 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of tissue plasminogen activator to revive blebs following intraocular surgery.

    Smith MF, Doyle JW.

    Arch Ophthalmol. 2001 Jun;119(6):809-12.PMID: 11405830 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity